BraunwaldE. Effects of coronary artery grafting on survival: Implications of the randomized coronary artery surgery study. N Engl J Med1983;309:1181–4.
3.
LoopFDLytleBWCosgroveDMStewartBWGoormasticMWilliamsGWInfluence of the internal mammary artery on 10 year survival and other cardiac events. N Engl J Med1986;314:1–6.
4.
LuscherTF. Vascular biology of coronary bypass grafts: Basic aspects and clinical implications. Curr Opinion Cardiol1991;6:868–76.
5.
OkiesJEPageUSBigelowJCKrauseAHSolomonMW. The left internal mammary artery the graft of choice. Circulation1984;70(suppl 1):213–21.
6.
MorrisJJSmithLRGlowerDGMuhlbaierLHRevesJGWechslerASClinical evaluation of single versus multiple mammary artery bypass. Circulation1990;82(suppl IV):214–23.
7.
AngeliniGDBryanAJ. Extending the use of autologous arterial conduits in myocardial revascularisation. Br Heart J1992;68:161–2.
8.
AngeliniGDBryanAJWestRRNewbyACBrekenridgeIM. Coronary artery bypass surgery: Current practice in the United Kingdom. Thorax1989;44:721–4.
9.
Assad-MorellJLFryeRLConnollyDCDaviesGDPluthJRWallaceRBAorto-coronary artery saphenous vein bypass surgery: Clinical and angiographic results. Mayo Clin Proc1975;50:379–83.
10.
FusterVChesebroJH. Aorto-coronary artery vein graft disease: Experimental and clinical approach for the understanding of the role of platelets and platelet inhibitors. Circulation1985;72(suppl V):65–70.
11.
FuchsJCAMitchenerJSHagenPO. Post-operative changes in autologous vein grafts. Ann Surg1978;188:1–15.
12.
GrondinCMCampeauLLesperenceJEnjalbertMBourassaMG. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation1984;70(suppl 1):208–12.
13.
JosaMLieJTBiancoRLKayeMP. Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol1981;24:1248–54.
14.
ChesebroJHClementsIPFusterVElvebackLRSmithHCBardsleyWTA platelet inhibitor drug trial in coronary artery bypass operations: Benefit of peri-operative dipyridamole and aspirin therapy on early postoperative vein graft patency. N Engl J Med1982;307:73–8.
15.
PfistererMBurkartFJockersGMeyerBRegenassSBurckhardtDTrial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Lancet1989;ii:1–7.
16.
MetkeMPLieFTFusterVJosaMKayeMP. Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol1979;43:1144–8.
17.
FusterVChesebroJH. Role of platelets and platelet inhibitors in aortocoronary vein-graft disease. Circulation1986;73:227–32.
18.
SchwartzRSHolmesDRTopolEJ. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol1992;20:284–93.
19.
BlankenhornDHNessimSAJohnsonRLSanmarcoMEAzenSPCashin-HemphillL. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and venous bypass grafts. JAMA1987;257:3233–40.
20.
VerstraeteMBrownBGChesebroJHEkestromSHarkerLAHendersonAHEvaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J1986;7:4–13.
21.
GoldmanSCopelandJMoritzTHendersonWZadinaKOvittTImprovement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy. Circulation1988;77:1324–32.
22.
BrownBGCukinghamRADeRouenTGoedeLVWongMFeeHJImproved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation1985;72:138–46.
23.
SanzGPajaronAAlegriaECoelloICardonaMFournierJAPrevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Circulation1990;82:765–73.
24.
van der MeerJHillegeJLvan GilstWHLieKI. One year venous graft patency after coronary bypass surgery is improved by addition of dipyridamole to low dose aspirin [Abstract]. Eur Heart J1992;13:913.
CatinellaFPCunninghamJNSrungaramRKBaumannFGNathanIMGlassmanEAThe factors influencing early patency of coronary artery bypass grafts. J Thorac Cardiovasc Surg1982;83:686–700.
27.
PanteleyGAGoodnightSHRahimtoolaSHarlanBJDeMotsHCalvinLFailure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary artery bypass. N Engl J Med1979;301:962–6.
28.
SharmaGVRKKhuriSFJosaMFollandEDParisiAF. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. Circulation1983;68(suppl II):218–21.
29.
HendersonWGGoldmanSCopelandJGMoritzTEHarkerLA. Antiplatelet or anticoagulant therapy after coronary artery bypass surgery: A meta-analysis of clinical trials. Ann Int Med1989;111:743–50.
30.
SethiGKCopelandJGGoldmanSMoritzTZadinaKHendersonWG. Implications of pre-operative administration of aspirin in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol1990;15:15–20.
31.
GoldmanSCopelandJGMoritzTHendersonWGZadinaKOvittTStarting aspirin therapy after operation: Effects on early graft patency. Circulation1991;84:520–6.
32.
GavaghanTPGebskiVBaronDW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. Circulation1991;83:1526–33.
33.
FrickMHValleMHarjolaPT. Progression of coronary artery disease in randomised medical and surgical patients over a 5 year angiographic follow up. Am J Cardiol1983;52:681–5.
34.
DesforgesJF. The use of aspirin in ischaemic heart disease. N Engl J Med1992;327:175–81.
35.
UnderwoodMJPringleSde BonoDP. Reduction of thrombus formation in vivo using a thrombolytic agent targeted at damaged endothelial cells. Br J Surg1992;79:915–17.
